Biocon MD Kiran Mazumdar-Shaw Named EY World Entrepreneur Of The Year
Kiran Mazumdar Shaw, Executive Chairperson and Managing Director of Biocon Limited, has been named EY World Entrepreneur Of The Year for 2020.
The Biocon MD was picked from among 46 nominations from 41 countries.
She also becomes the second woman to hold the title, following Olivia Lum of Hyflux Limited from Singapore in 2011.
Kiran, 67, founded Biocon, a bio-enzymes company, in 1978 with just two employees and $500. The company is now employs more than 11,000 people.
“My business focus is global health care and the provision of universal access to life saving medicine; however, my responsibility as an entrepreneur is greater than simply delivering value to shareholders. Wealth creation can be a catalyst for change, and all entrepreneurs have a responsibility to the world around them and the communities in which they operate," Shaw said after the award announcement.
ALSO READ: Buy Sun Pharma June Futures at Rs 496: Nandish Shah of HDFC Securities
"Women also play a hugely important role in economic development, and for too long their contribution has been ignored. It’s important that we use the platform of EY World Entrepreneur Of The Year to encourage more women to participate in entrepreneurial pursuits. I’m truly honored to receive this prestigious award," she added.
She is the third award winner from India. Managing Director of Kotak Mahindra Bank, Uday Kotak (2014) and Infosys founder Narayana Murthy (2005) are the former recipients.
Manny Stul, Chairman and Co-CEO of Moose Toys and Chair of the EY World Entrepreneur Of The Year judging panel, says, "Kiran is an inspirational entrepreneur who demonstrates that determination, perseverance and a willingness to innovate can create long-term value. The judging panel were impressed by her ability to build and sustain growth over the past 30 years and by her integrity and passion for philanthropy that has delivered huge global impact. She has built India’s largest biopharmaceutical company on a foundation of compassionate capitalism and putting patient needs before profits.”
“Dr Shaw’s recognition is a moment of tremendous pride for Indian entrepreneurship. She is truly a winner on several counts - not only has she shown tremendous vision and fortitude to grow Biocon into a market-leading, innovation-driven biotechnology organization which has created a global impact, but she has also made her mark as a torchbearer of diversity, a voice of Indian industry and a frontrunner in philanthropy and giving back to the society,” said Rajiv Memani, EY India Chairman and Regional Managing Partner.
Coutts Sets Scope On New Continent
Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more
From Cypherpunk To Citadel
How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more
ACB Securities: Building Scale, Trust & Innovation
ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more
War Risk Returns To Markets As VIX Surges
For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more
Stablecoin The Future Of Currency?
The payments system is undergoing a quiet but consequential shift. What was once the exclusive preserve of central banks... Read more
BoE Loosens Capital Rules
The Bank of England has taken a significant step towards easing post-crisis regulation by lowering its estimate of the c... Read more